New sources and new antitumor drugs in development
Weiss, R.B.
Seminars in Oncology 24(2): 153-155
1997
ISSN/ISBN: 0093-7754 PMID: 9129685 Document Number: 474375
Document emailed within 1 workday
Related Documents
Reztsova, V.V. 2007: Potential of lignin application in development of new antitumor drugs Voprosy Onkologii 53(5): 505-509Vaara, M. 1998: Sources for antibacterial drugs are not drying up Duodecim; Laaketieteellinen Aikakauskirja 114(7): 615; 617
Prendergast, M.M. 2000: Sources of bias in the economic analysis of new drugs JAMA 283(11): 1424
Le Pen, C. 2000: Sources of bias in the economic analysis of new drugs JAMA 283(11): 1423-1424
Behera, D.; Malik, S.K. 1984: Antitumor drugs in inoperable lung cancer Indian Journal of Chest Diseases and Allied Sciences 26(1): 60-61
Wong, E.; Giandomenico, C.M. 1999: Current status of platinum-based antitumor drugs Chemical Reviews 99(9): 2451-2466
Antonini, I.; Polucci, P.; Cola, D.; Palmieri, G.; Martelli, S.; Bontemps-Gracz, M. 1993: Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs Farmaco 48(12): 1641-1648
Pokrovskiĭ, V.S.; Lesnaia, N.A.; Treshchalina, E.M.; Lukasheva, E.V.; Berezov, T.T. 2011: Perspectives of developing enzyme-based antitumor drugs Voprosy Onkologii 57(2): 155-164
Garin, A.M.; Bazin, I.S. 1997: The role of antitumor drugs in treating stomach cancer patients Terapevticheskii Arkhiv 69(2): 16-18
1980: Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations National Cancer Institute Monograph 1980(55): 1-179
Simpkins, H.; Pearlman, L.F. 1986: Interaction of two second generation platinum antitumor drugs with mouse thymocytes Cancer Research 46(3): 1433-1439
Allen, L.V. 2006: Basics of compounding for hazardous drugs, part 2: regulation and sources of contamination International Journal of Pharmaceutical Compounding 10(6): 446-448
Furuta, T.; Yokokura, T. 1991: Combination therapy of CPT-11, a camptothecin derivative, with various antitumor drugs against L 1210 leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(3): 393-402
Grigorescu, E.; Gaiţă, G. 1974: Macromolecules of plant origin as sources of raw material in semisynthesis of drugs. I. Biogenesis of lignin Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 78(1): 129-135
Tiewcharoen, S.; Junnu, V.; Suvoutho, S. 2003: Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources Journal of the Medical Association of Thailand 86(9): 876-882
Cohen, M.H. 1975: Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by various psychotropic drugs in combination with caffeine Journal of Pharmacology and Experimental Therapeutics 194(3): 475-479
Beskrovnyĭ, A.M. 1970: A method of testing the antitumor effectiveness of drugs on induced rat mammary gland cancer Voprosy Onkologii 16(8): 62-66
Al-Gailany, K.A. 1990: Spectrofluorometric studies on the binding of the antitumor drugs ametantrone and mitoxantrone to bovine serum albumin Biomedica Biochimica Acta 49(10): 1091-1096
Nagasawa, M.; Ishii, S.; Kariya, Y.; Itoh, O.; Yamamoto, H.; Kawaharajo, K.; Takeuchi, T. 1990: In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 1): 633-638
Serafino, A.; Sinibaldi-Vallebona, P.; Pierimarchi, P.; Bernard, P.; Gaudiano, G.; Massa, C.; Rasi, G.; Ranagnan, G. 1999: Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering? Anticancer Research 19(3a): 1909-1918